T1	HMM 0 55	Cardiovascular safety and gastrointestinal tolerability
T2	HMM 167 227	cardiovascular (CV) and other safety and efficacy parameters
T3	HMM 643 679	Other safety and efficacy parameters
T4	HMM 866 902	thrombotic CV risk hazard ratio (HR)
T5	HMM 1025 1105	cumulative gastrointestinal (GI)/liver adverse events (AEs) discontinuation rate
T6	HMM 1306 1360	maximum average change in systolic blood pressure (BP)
T7	HMM 1553 1561	efficacy
T8	HMM 1650 1678	risk of thrombotic CV events
T9	HMM 1775 1799	risk of renovascular AEs
T10	HMM 1823 1853	GI/liver tolerability profile.
